Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should ...

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That ...

India's pharmaceutical and biopharmaceutical industry has welcomed the Union Budget 2026, particularly the launch of the ...

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is no longer linear, nor even merely non-linear, but fundamentally ...

Takeda Pharmaceutical Company Limited ( TAK) Q3 2026 Earnings Call January 29, 2026 5:30 AM EST ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

As pharma raced to meet climate targets in 2024 to 2025, it proved that scaling medicines no longer has to mean scaling emissions.

DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...

Pharma companies face declining profits as the lenalidomide opportunity fades, impacting future growth and margins.

Mayne Pharma Group Limited ( MAYNF) Shareholder/Analyst Call January 28, 2026 6:00 PM EST ...

The concept of shifting government funds away from encouraging comprehensive coverage to one that might leave many Americans ...

Affordable medicine and a skilled workforce are the backbone of growth. But with the pharma industry under strain, both are now at risk, threatening Bangladesh’s economic momentum ...